The U.S. government on Friday proposed 2026 reimbursement rates for Medicare Advantage plans run by private insurers that ...
Congress recently pulled a similar stunt on Medicare beneficiaries. But in this case, the result was more than just ...
AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...
Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, CNBC reported on ...
Any lasting fiscal reforms must moderate the growth of the largest mandatory spending programs: Social Security, Medicare and ...
Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate ...
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...
It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...
Health insurance companies selling private Medicare Advantage plans in the US would see a greater increase in payments in ...
MA plans are substantially overpaid compared to traditional Medicare. Much of these overpayments benefit the MA plans rather ...
As our population continues to age, Medicare’s role in the American health care system continues to grow. And Medicare’s ...
The Better Medicare Alliance urged President-elect Donald Trump to reconsider these Medicare Advantage policies once he takes ...